Combination weight loss treatment for adults with obesity
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a combination of two medications—a growth hormone-like drug and a semaglutide injection—to help adults with obesity lose weight. It aims to see if this combination is safe and effective for people who have not used these medications before.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- Your body mass index (BMI) is 28 or higher.
- You have not used semaglutide or any diabetes medication before.
- You are willing to use effective birth control and not plan pregnancy or sperm/egg donation during the study.
- You have no major health problems like heart disease, cancer, or thyroid issues that could increase risk.
- Your weight has been stable (within 5%) in the last 3 months.
- You can attend regular follow-up visits and perform self-injections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called semaglutide (a once-weekly injection) to help people with obesity lose weight. It is for adults who have already tried lifestyle changes without success.
This study tests a weekly injection called semaglutide to see how well it helps people with obesity lose weight, compared to a similar approved medicine, Wegovy. It may be an option if you have struggled to lose weight in the past.
This study tests a nasal spray containing semaglutide (a GLP-1 receptor agonist) to see if it helps adults who are overweight or obese lose weight. It may be an option if you have a BMI between 27 and 35 and have not used other weight loss medications recently.
This study tests a weight loss program that combines a weekly medicine injection with lifestyle coaching for teens with obesity. It aims to help teens achieve a healthier weight and improve overall wellness.
This study tests whether a low dose of semaglutide (a once-weekly injection) can help obese adults without diabetes lose weight. Semaglutide works by reducing appetite and helping your body use food differently.
This study tests whether a GLP-1 medication (a type of drug that helps with weight loss) can safely and effectively help young adults with type 1 diabetes who also have obesity. It aims to see if adding this treatment to insulin can improve weight and blood sugar control.
Hear when a new Non-diabetic Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.